0

Tacrolimus

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP109581933-A
CAS109581-93-3
Structure
MDL NumberMFCD11045918
Molecular Weight822.03
InChI KeyNWJQLQGQZSIBAF-MLAUYUEBSA-N
DescriptionUnited States Pharmacopeia (USP) Reference Standard
Formneat
Size150MG
1

An Update on the Safety of Tacrolimus in Kidney Transplant Recipients, With a Focus on Tacrolimus Minimization

Thomas Jouve, Johan Noble, Lionel Rostaing, Paolo Malvezzi

Expert Opin Drug Saf. 2019 Apr;18(4):285-294.

PMID: 30909754

1

Clinical Pharmacokinetics of Tacrolimus

R Venkataramanan, A Swaminathan, T Prasad, A Jain, S Zuckerman, V Warty, J McMichael, J Lever, G Burckart, T Starzl

Clin Pharmacokinet. 1995 Dec;29(6):404-30.

PMID: 8787947

1

New Formulations of Tacrolimus and Prevention of Acute and Chronic Rejections in Adult Kidney-Transplant Recipients

Thomas Jouve, Lionel Rostaing, Paolo Malvezzi

Expert Opin Drug Saf. 2017 Jul;16(7):845-855.

PMID: 28494654

1

Tacrolimus - Pharmacokinetic Considerations for Clinicians

Katharina Schutte-Nutgen, Gerold Tholking, Barbara Suwelack, Stefan Reuter

Curr Drug Metab. 2018;19(4):342-350.

PMID: 29298646

1

Evaluate Regimens Using Either Maraviroc, Bortezomib, or Post-transplantation Cyclophosphamide for GvHD Prophylaxis

Javier Bolaños-Meade, Ran Reshef, Raphael Fraser, Mingwei Fei, Sunil Abhyankar, Zaid Al-Kadhimi, Amin M Alousi, Joseph H Antin, Sally Arai, Kate Bickett, Yi-Bin Chen, Lloyd E Damon, Yvonne A Efebera, Nancy L Geller, etc.

Lancet Haematol. 2019 Mar;6(3):e132-e143.

PMID: 30824040

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode